舒文静;彭军;江高峰;

• 1:武汉科技大学附属天佑医院
• 2:武汉科技大学附属天佑医院转化医学中心肿瘤免疫治疗研究所

摘要(Abstract)：

中枢神经系统肿瘤是最常见的中枢神经系统疾患之一,致残、致死率很高。在过去的几十年里,神经系统肿瘤的临床治疗一直困扰着人们,但诱导多能干细胞的成功建立及其生物学功能的最新进展,为再生医学领域开发神经系统肿瘤新的治疗方法注入了动力。诱导多能干细胞作为一种替代受损中枢神经系统细胞、促进功能恢复的理想治疗干预手段,为神经系统肿瘤的治疗提供了新的思路。本文综述了诱导多能干细胞在神经系统肿瘤治疗方面的最新研究进展。

关键词(KeyWords)： 诱导多能干细胞;神经干细胞;胶质瘤;髓母细胞瘤;神经母细胞瘤

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目（编号：81773264;81572495）

作者(Authors): 舒文静;彭军;江高峰;

参考文献(References)：

• [1]MARSON A,LEVINE S S,COLE M F,et al.Connecting micro RNA genes to the core transcriptional regulatory circuitry of embryonic stem cells[J].Cell,2008,134(3):521-33.DOI:10.1016/j.cell.2008.07.020.
• [2]YAMANAKA S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by four transcription factorsy[J].Cell Prolif,2008,41(suppl 1):51-56.DOI:10.1111/j.1365-2184.2008.00493.x.
• [3]GUILLOT P V.Induced pluripotent stem(i Ps)cells from human fetal stem cells[J].Best Pract Res Clin Obstet Gynaecol,2016,31:112-120.DOI:10.4161/org.25197.
• [4]SHI Y,INOUE H,WU J C,et al.Induced pluripotent stem cell technology:a decade of progress[J].Nat Rev Drug Discov,2017,16(2):115-130.DOI:10.1038/nrd.2016.245.
• [5]TAKENAKA C,NISHISHITA N,TAKADA N,et al.Effective generation of i PS cells from CD34+cord blood cells by inhibition of p53[J].Exp Hematol,2010,38(2):154-162.DOI:10.1016/j.exphem.2009.11.003.
• [6]GU H,HUANG X,XU J,et al.Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood[J].Stem Cell Res Ther,2018,9(1):163.DOI:10.1186/s13287-018-0908-z.
• [7]UMEGAKI-ARAO N,PASMOOIJ A M,ITOH M,et al.Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa[J].Sci Transl Med,2014,6(264):264ra164.DOI:10.1126/scitranslmed.3009342.
• [8]WIEDEMANN A,HEMMER K,BERNEMANN I,et al.Induced pluripotent stem cells generated from adult bone marrow-derived cells of the nonhuman primate(Callithrix jacchus)using a novel quad-cistronic and excisable lentiviral vector[J].Cell Reprogram,2012,14(6):485-496.DOI:10.1089/cell.2012.0036.
• [9]QU X,LIU T,SONG K,et al.Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions[J].PLo S One,2012,7(10):e48161.DOI:10.1371/journal.pone.0048161.
• [10]FUSAKI N,BAN H,NISHIYAMA A,et al.Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus,an RNA virus that does not integrate into the host genome[J].Proc Jpn Acad Ser B Phys Biol Sci,2009,85(8):348-362.DOI:10.2183/pjab.85.348.
• [11]NARSINH K H,JIA F,ROBBINS R C,et al.Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors[J].Nat Protoc,2011,6(1):78-88.DOI:10.1038/nprot.2010.173.
• [12]WARREN L,MANOS P D,AHFELDT T,et al.Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified m RNA[J].Cell Stem Cell,2010,7(5):618-630.DOI:10.1016/j.stem.2010.08.012.
• [13]KIM D,KIM C H,MOON J I,et al.Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins[J].Cell Stem Cell,2009,4(6):472-476.DOI:10.1016/j.stem.2009.05.005.
• [14]HOU P,LI Y,ZHANG X,et al.Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds[J].Science,2013,341(6146):651-654.DOI:10.1126/science.1239278.
• [15]KIMBREL E A,LANZA R.Current status of pluripotent stem cells:moving the first therapies to the clinic[J].Nat Rev Drug Discov,2015,14(10):681-692.DOI:10.1038/nrd4738.
• [16]HUANGFU D,MAEHR R,GUO W,et al.Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds[J].Nat Biotechnol,2008,26(7):795-797.DOI:10.1038/nbt1418.
• [17]CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in the China[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
• [18]BEGUM A N,GUOYNES C,CHO J,et al.Rapid generation of sub-type,region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres[J].Stem Cell Res,2015,15(3):731-741.DOI:10.1016/j.scr.2015.10.014.
• [19]CHOI H W,KIM J S,CHOI S,et al.Neural stem cells differentiated from i PS cells spontaneously regain pluripotency[J].Stem cells,2014,32:2596-2604.DOI:10.1002/stem.1757.
• [20]ABOODY K S,NAJBAUER J,DANKS M K.Stem and progenitor cell-mediated tumor selective gene therapy[J].Gene Ther,2008,15:739-752.DOI:10.1038/gt.2008.106.
• [21]FRANK R T,NAJBAUER J,ABOODY K S.Concise review:stem cells as an emerging platform for antibody therapy of cancer[J].Stem Cells,2010,28:2084-2087.DOI:10.1002/stem.513.
• [22]AHMED A U,THACI B,ALEXIADES N G,et al.Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma[J].Mol Ther,2011,19:1714-1726.DOI:10.1038/mt.2011.100.
• [23]FRANK R T,EDMISTON M,KENDALL S E,et al.Neural stem cells as a novel platform for tumorspecific delivery of therapeutic antibodies[J].PLoS One,2017,4(12):e8314.DOI:10.1371/journal.pone.0008314.
• [24]ABOODY K S,NAJBAUER J,METZ M Z,et al.Neural stem cell-mediated enzyme/prodrug therapy for glioma:preclinical studies[J].Sci Transl Med,2013,5(184):184ra59.DOI:10.1126/scitranslmed.3005365.
• [25]BAGO J R,ALFONSO-PECCHIO A,OKOLIE O,et al.Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma[J].Nat Commun,2016,7:10593.DOI:10.1038/ncomms10593.
• [26]KIM S K,KIM S U,PARK I H,et al.Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression[J].Clin Cancer Res,2006,12 (18):5550-5556.
• [27]BAGO J R,PEGNA G J,OKOLIE O,et al.Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer[J].Biomaterials,2016,84:42-53.DOI:10.1016/j.biomaterials.2016.01.007.
• [28]ABOODY K S,BROWN A,RAINOV N G,et al.Neural stem cells display extensive tropism for pathology in adult brain:evidence from intracranial gliomas[J].Proc Natl Acad Sci USA,2000,97(23):12846-12851.DOI:10.1073/pnas.97.23.12846.
• [29]KAUER T M,FIGUEIREDO J L,HINGTGEN S,et al.Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas[J].Nat Neurosci,2012,15(2):197-204.DOI:10.1038/nn.3019.
• [30]TSAI Y T,WU A C,YANG W B,et al.ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade[J].Int J Mol Sci,2019,20(22):5625.DOI:10.3390/ijms20225625
• [31]孙广大，李文媛，马多，等.KLF7对骨髓间充质干细胞增殖和施万样细胞分化的影响[J].中国实用神经疾病杂志，2020,23(14):1197-1202.DOI:10.12083/SYSJ.2020.14.272.
• [32]ABOODY K S,NAJBAUER J,METZ M Z,et al.Neural stem cell-mediated enzyme-prodrug therapy for glioma:preclinical studies[J].Sci Transl Med,2013,5(184):184ra59.DOI:10.1126/scitranslmed.3005365.
• [33]BAGO J R,SHEETS K T,HINGTGEN S D.Neural stem cell therapy for cancer[J].Epub,2016,99:37-43.DOI:10.1016/j.ymeth.2015.08.013.
• [34]MOONEY R,HAMMAD M,BATALLA-COVELLO J,et al.Concise review:neural stem cell-mediated targeted cancer therapies[J].Stem Cells Transl Med,2018,7(10):740-747.DOI:10.1002/sctm.18-0003.
• [35]EHTESHAM M,KABOS P,GUTIERREZ M A,et al.Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand[J].Cancer Res,2002,62:7170-7174.
• [36]BALYASNIKOVA I V,FERGUSON S D,HAN Y,et al.Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts[J].Cancer Lett,2011,310:148-159.DOI:10.1016/j.canlet.2011.06.029.
• [37]POLKINGHORN W R,TARBELL N J.Medulloblastoma:tumorigenesis,current clinical paradigm,and efforts to improve risk stratification[J].Nat Clin Pract Oncol,2007,4(5):295-304.DOI:10.1038/ncponc0794.
• [38]RUTKOWSKI S.Current treatment approaches to early childhood medulloblastoma.Expert review of neurotherapeutics[J].Expert Rev Neurother,2006,6(8):1211-1221.DOI:17.1212/sctm.14-0243.
• [39]RAMASWAMY V,REMKE M,BOUFFET E,et al.Recurrence patterns across medulloblastoma subgroups:an integrated clinical and molecular analysis[J].Lancet Oncol,2013,14 (12):1200-1207.DOI:10.1016/S1470-2045(13)70449-2.
• [40]GUTOVA M,SHACKLEFORD G M,KHANKALDYY-AN V,et al.Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblatoma[J].Gene Ther,2013,20(2):143-150.DOI:10.1038/gt.2012.12.
• [41]OKOLIE O,IRVIN D M,BAGO J R,et al.Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection[J].PLo S One,2018,13(7):e0198596.DOI:10.1371/journal.pone.0198596.
• [42]BAI R Y,STAEDTKE V,RUDIN C M,et al.Effective treatment of diverse medulloblastomamodels with mebendazole and its impact on tumor angiogenesis[J].Neuro Oncol,2015,17(4):545-554.DOI:10.1093/neuonc/nou234.
• [43]WANG J,LI K.Recent advances in new drugs for neuroblastoma[J].Chin J Pediatr Surg,2019,40(6):558-562.DOI:10.15313/j.cnki.1871-3141.2019.53.012.
• [44]GUTOVA M,GOLDSTEIN L,METZ M,et al.Optimization of a neural stem-cell-mediated carboxylesterase/irinotecan gene therapy for metastatic neuroblastoma[J].Mol Ther Oncolytics,2016,4:67-76.DOI:10.1016/j.omto.2016.11.004.